Reesha Ahmed, a pregnant woman in Texas, was charged over $9,000 by her local hospital for routine blood tests. Even after her insurer negotiated the amount down and paid a portion, Ahmed was left with a bill of over $2,000. The situation, which occurred in tandem with Ahmed’s miscarriage, highlights issues with hospitals’ high fees for tests and procedures. After a reporter contacted Texas Health Hospital, Ahmed’s medical debt was waived. This issue demonstrates the importance of patients seeking out cost-effective options for standard tests, highlighting the potential for unnecessary financial burden when using hospital labs.
FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder
Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy developed to treat leukocyte-adhesion deficiency type 1, an inherited immunodeficiency that can become fatal to
